1. Home
  2. ARQQ vs EOLS Comparison

ARQQ vs EOLS Comparison

Compare ARQQ & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$14.51

Market Cap

250.9M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.26

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
EOLS
Founded
2017
2012
Country
United Kingdom
United States
Employees
91
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
284.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ARQQ
EOLS
Price
$14.51
$5.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$60.00
$15.50
AVG Volume (30 Days)
344.4K
714.1K
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$381.13
$13.27
Revenue Next Year
$212.00
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$11.52
$3.86
52 Week High
$62.00
$12.28

Technical Indicators

Market Signals
Indicator
ARQQ
EOLS
Relative Strength Index (RSI) 49.76 65.25
Support Level $11.72 $4.02
Resistance Level $17.75 $7.29
Average True Range (ATR) 1.20 0.24
MACD 0.16 0.12
Stochastic Oscillator 45.72 83.72

Price Performance

Historical Comparison
ARQQ
EOLS

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: